March 16 (Reuters) - Attana AB ATANA.NGM :
* ATTANA AB WILL SUPPORT AND COLLABORATE WITH PROF. SALANTI
IN
DEVELOPING A VACCINE AGAINST CORONAVIRUS
* CONSORTIUM WILL BASE PROJECT ON THEIR PREVIOUSLY DEVELOPED
METHOD FOR VACCINE DEVELOPMENT
* GRANT WILL BE USED TO DEVELOP A VACCINE AGAINST NEW TYPE
OF
CORONAVIRUS DISEASE, COVID-19, WHICH AT MOMENT IS SPREADING
WORLDWIDE
* IN COLLABORATION WITH UNIVERSITY OF TÜBINGEN, LEIDEN
UNIVERSITY
MEDICAL CENTER, WAGENINGEN UNIVERSITY AND COMPANIES ADAPTVAC AND
EXPRES2ION, RESEARCHERS FROM UNIVERSITY OF COPENHAGEN HAVE
RECEIVED A GRANT FROM EU OF EUR 2.7 MILLION
Source text for Eikon: ID:nWkr7kl4GK
Further company coverage: ATANA.NGM
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))